Mead, G M <br/><br/>
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2002 
 - 1264-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdf253  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Burkitt Lymphoma--drug therapy<br/>Cyclophosphamide--therapeutic use<br/>Cytarabine--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Drug Evaluation<br/>Etoposide--therapeutic use<br/>Female<br/>Humans<br/>Ifosfamide--therapeutic use<br/>L-Lactate Dehydrogenase--metabolism<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Prospective Studies<br/>Risk Factors<br/>Survival Rate<br/>Treatment Outcome<br/>United Kingdom<br/>Vincristine--therapeutic use